Press Release: Sanofi and Cheplapharm to create new strategic partnership in mature medicines

{
  "signal_id": "c0860517-c280-2138-2861-28962b7cc8fa",
  "signal_type": "news",
  "signal_subtype": "partners_with",
  "detected_at": "2026-09-14T13:03:00+00:00",
  "company": {
    "name": "Sanofi",
    "domain": "sanofi.com"
  },
  "data": {
    "url": "https://www.globenewswire.com/news-release/2026/09/14/3361178/0/en/press-release-sanofi-and-cheplapharm-to-create-new-strategic-partnership-in-mature-medicines.html",
    "title": "Press Release: Sanofi and Cheplapharm to create new strategic partnership in mature medicines",
    "excerpt": "Sanofi and Cheplaphar m to create new strategic partnership i n mature medicines Paris , September 14, 2026 . Sanofi and Cheplapharm, a European leader in well-established medicines, today announced their intention to create a strategic partnership under which Cheplapharm would take over from Sanofi a selection of 20 mature medicines and three manufacturing sites worldwide. In return, Sanofi will receive a 26.4% equity stake in Cheplapharm, building on a collaboration that started in 2014. The partnership is based on a shared conviction: that innovative medicines and certain mature medicines have different needs and should benefit from operating models tailored to their specific manufacturing, regulatory and commercial requirements. Cheplapharm's specialized expertise will ensure these medicines continue to meet patients' needs throughout the next stage of their lifecycle. \" Our multi-year journey to simplify our mature portfolio has enabled us to focus on innovation while ensuring mature medicines continue to reach patients who need them. Cheplapharm has been a trusted partner for more than a decade and this transaction significantly builds on its prior acquisitions from Sanofi's mature medicines portfolio. This new partnership, together with our equity stake in Cheplapharm , underscores our commitment to ensuring patients continue to benefit from today’s essential medicines...",
    "summary": "Sanofi and Cheplapharm announced their intention to create a strategic partnership, under which Cheplapharm will acquire a selection of 20 mature medicines and three manufacturing sites from Sanofi.",
    "location": "Paris, France",
    "planning": true,
    "image_url": "https://ml-eu.globenewswire.com/Resource/Download/06da731a-67a1-4258-939f-6ef0531ee3bf",
    "confidence": 0.95,
    "published_at": "2026-09-14T13:03:00Z",
    "location_data": [
      {
        "city": "Paris",
        "state": "Île-de-France",
        "region": "Western Europe",
        "country": "France",
        "continent": "Europe",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "Sanofi and Cheplapharm, a European leader in well-established medicines, today announced their intention to create a strategic partnership under which Cheplapharm would take over from Sanofi a selection of 20 mature medicines and three manufacturing sites worldwide.",
    "related_company_name": "Cheplapharm",
    "related_company_domain": "cheplapharm.com"
  }
}

curl https://signals.autobound.ai/v1/signals/c0860517-c280-2138-2861-28962b7cc8fa \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"sanofi.com","limit":20}'